647834-15-9COc1ccc(Cc2sccc2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1BUXGTLNOWLNUKF-SOVHRIKKSA-NAtigliflozin is a small molecule drug. Atigliflozin is under investigation in clinical trial NCT00361738 (Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment). Atigliflozin has a monoisotopic molecular weight of 382.11 Da.
647834-15-9CHEMBL5314949Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…